ArticleBiological psychiatry. Cognitive neuroscience and neuroimaging2026
The T1-Weighted/T2-Weighted Ratio as an In Vivo Proxy for Reduced Intracortical Myelin Content in Youth With RASopathies: A Cross-Sectional Study.
Article in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
backgroundMyelin may represent a modifiable treatment target in neurodevelopmental disorders, but accessible in vivo tools for assessing myelin alterations in clinical settings are limited. The T1-weighted/T2-weighted (T1w/T2w) ratio, derived from standard magnetic resonance imaging (MRI), offers a proxy for cortical myelin and may aid in detecting abnormalities. Leveraging a genetics-first approach, we tested whether youth with RASopathies, neurodevelopmental disorders caused by RAS-MAPK (mitogen-activated protein kinase) variants, show differences in cortical myelin measured using T1w/T2w ratios compared with typically developing (TD) peers.
methodsIn this prospective study, 112 youth (86 with RASopathies, 26 TD; ages 6-17 years) completed T1w and T2w MRI scans and NIH Toolbox cognitive assessments; parent-rated mobility and strength impact scores were also collected. T1w/T2w ratios were calculated at cortical depths in FreeSurfer, and average values were extracted from 68 regions of interest (ROIs). Group differences were assessed using analysis of covariance with false discovery rate (FDR) correction. Correlations between regional T1w/T2w ratios and mobility, strength, and cognitive scores were examined.
resultsWidespread decreases in T1w/T2w ratios were found in the RASopathies group compared with the TD group. Among ratios sampled at mid-depth, 63 of 68 cortical ROIs were reduced in individuals with RASopathies (p
conclusionsThe T1w/T2w ratio may serve as a sensitive tool for detecting microstructural alterations in genetically defined neurodevelopmental disorders. Future work is needed to clarify the biological underpinnings and clinical relevance of T1w/T2w ratios for cognitive and functional outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.